Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine
To access this article, please choose from the options below
PII: S0305-7372(02)90245-8
doi:10.1053/ctrv.2002.0245
© 2001 Harcourt Publishers Ltd. All rights reserved.
